InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.170
-0.070 (-5.65%)
At close: Nov 13, 2026, 4:00 PM EST
1.140
-0.030 (-2.56%)
After-hours: Nov 13, 2026, 7:30 PM EST
InflaRx Market Cap
InflaRx has a market cap or net worth of $172.42 million as of November 13, 2026. It is the 21,399th most valuable company in the world and the 3,637th biggest in the United States. Its market cap has increased by 74.34% in one year.
Market Cap
172.42M
Enterprise Value
42.29M
1-Year Change
74.34%
Global Rank
Country Rank
#3,637 United States
Category
ChartMarket Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $350.90M to $172.42M, a decrease of -50.86%. That is a compound annual growth rate of -7.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 172.40M | 152.05% |
| Dec 31, 2025 | 68.40M | -52.96% |
| Dec 31, 2024 | 145.40M | 51.46% |
| Dec 29, 2023 | 96.00M | -29.93% |
| Dec 30, 2022 | 137.00M | -34.85% |
| Dec 31, 2021 | 210.30M | 60.17% |
| Dec 31, 2020 | 131.30M | 27.72% |
| Dec 31, 2019 | 102.80M | -88.13% |
| Dec 31, 2018 | 866.00M | 76.55% |
| Dec 29, 2017 | 490.50M | 39.78% |
| Nov 8, 2017 | 350.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alpha Cognition | 180.76M |
| Whitehawk Therapeutics | 180.57M |
| Sol-Gel Technologies | 180.46M |
| Eledon Pharmaceuticals | 178.80M |
| AN2 Therapeutics | 172.64M |
| Invivyd | 171.58M |
| BridgeBio Oncology Therapeutics | 171.57M |
| Yarrow Bioscience | 167.76M |